5 Key Takeaways
-
1
Novartis is constructing a 466,000-square-foot Biomedical Research center in San Diego, expected to open in 2029.
-
2
The facility will house approximately 1,000 employees and enhance Novartis' global research integration.
-
3
It will focus on drug discovery in neuroscience, oncology, and regenerative medicine, leveraging advanced technologies.
-
4
The center aims to strengthen scientific leadership and foster collaborations with biotech and academic partners.
-
5
This project is part of Novartis' USD 23 billion investment in the US, including multiple manufacturing facilities.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
